NEW YORK (GenomeWeb News) — DuPont's Qualicon business has licensed DxS' Scorpion multiplex assay platform for use in developing diagnostic tests for the food industry.

Under the agreement, DuPont Qualicon will use the Scorpions technology, a closed-tube platform for PCR analysis for which Manchester, UK-based DxS owns the worldwide intellectual property rights, for use in its development of rapid multiplex assays for detecting microorganisms in food as well as beverage safety and quality.

Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.